Italian Women Receive Groundbreaking Gene Therapy for Rare Blood Diseases

Pavia: Two Italian women in their twenties have made history by receiving pioneering gene therapy for rare hereditary blood diseases at San Matteo Hospital, marking a first for both Italy and Europe. The women, suffering from €š¬…¡¬‚¬¦¡¬‚¬Å¡¬¦¡¬‚¬Å¡¬€¦¡¬¦¡¬¦¸-thalassemia major and severe sickle cell anemia, underwent the advanced gene therapy known as “Casgevy”.

According to Ansa News Agency, this innovative treatment signifies a significant advancement in the management of hemoglobinopathies, which are severe and debilitating genetic diseases. €š¬…¡¬‚¬¦¡¬‚¬Å¡¬¦¡¬‚¬Å¡¬€¦¡¬¦¡¬¦¸-thalassemia and sickle cell anemia, specifically, are caused by mutations in the €š¬…¡¬‚¬¦¡¬‚¬Å¡¬¦¡¬‚¬Å¡¬€¦¡¬¦¡¬¦¸-globin gene, leading to serious hereditary hemoglobinopathies.

This procedure, carried out outside of clinical trials, highlights a new era in gene therapy application in Europe, offering hope to patients affected by similar genetic disorders.